OTC Monograph Woes No Surprise To FDA Commissioner Nominee Gottlieb

Gottlieb was asked only one question about OTC drug regulation during his confirmation hearing before the Senate HELP Committee, but it covered a large part of FDA's current concerns about the OTC market.